Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9H0S4
UPID:
DDX47_HUMAN
Alternative names:
DEAD box protein 47
Alternative UPACC:
Q9H0S4; B3KXP4; G5E955; Q96GM0; Q96NV8; Q9UI98
Background:
The Probable ATP-dependent RNA helicase DDX47, also known as DEAD box protein 47, plays a crucial role in ribosome biogenesis, mRNA splicing, and apoptosis. Its involvement in these fundamental cellular processes underscores its importance in maintaining cellular function and integrity.
Therapeutic significance:
Understanding the role of Probable ATP-dependent RNA helicase DDX47 could open doors to potential therapeutic strategies. Its pivotal role in critical cellular functions makes it a target of interest for drug discovery efforts aimed at treating diseases through modulation of ribosome biogenesis, mRNA processing, and apoptosis pathways.